Acacetin induces sustained ERK1/2 activation and RIP1-dependent necroptotic death in breast cancer cells
Toxicology and Applied Pharmacology · 2023-03 · 462 · 116409
DOI: 10.1016/j.taap.2023.116409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicology and Applied Pharmacology, 2023-03. Verfasst von Kushal Kandhari und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Central University of Gujarat, Gandhinagar, Gujarat, India; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: University Grants Commission, Central University of Gujarat, Jawaharlal Nehru University.
Abstract (Originalsprache)
Acacetin (AC), a naturally occurring flavonoid has shown anticancer potential. Herein, we studied the mechanisms of cell death and growth inhibition by AC in breast carcinoma T-47D and MDA-MB-231 cells. AC (10-40 μM) significantly decreased the levels of G2/M phase cyclins and CDKs, simultaneously increasing the expression of CDK inhibitors including Cip1/p21. A concentration-dependent increase in cell death was noted in both breast cancer cell lines with no such considerable effects on MCF-10A non-tumorigenic breast cells. The cell death-inducing potential of AC was further confirmed using confocal microscopy and flow cytometry analysis. AC resulted in mitochondrial superoxide generation, DNA damage, and ROS generation. N-acetyl cysteine (NAC) pre-treatment inhibited ROS generation and partially reversed ERK1/2 activation as well as cell death by AC. Further, AC enhanced the expression of RIP1 and RIP3, which mediate necroptosis. RIP1-specific inhibitor Necrostatin-1 (NS-1) reversed the AC-induced DNA damage and cell death. Collectively, these findings, for the first time, suggested that AC exerts its antitumor potential through ROS induction and RIP1-dependent necroptosis in breast carcinoma cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Central University of Gujarat, Gandhinagar, Gujarat, India; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical…
- School of Life Sciences, Central University of Gujarat, Gandhinagar, Gujarat, India.
- Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
- Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India. Electronic address: rana_singh@mail.jnu.ac.in.
Förderung
- University Grants Commission
- Central University of Gujarat
- Jawaharlal Nehru University
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Kandhari, K., Mishra, J. P. N., Agarwal, R., & Singh, R. P. (2023). Acacetin induces sustained ERK1/2 activation and RIP1-dependent necroptotic death in breast cancer cells. Toxicology and Applied Pharmacology, 462, 116409. https://doi.org/10.1016/j.taap.2023.116409
Vancouver
Kandhari K, Mishra JPN, Agarwal R, Singh RP. Acacetin induces sustained ERK1/2 activation and RIP1-dependent necroptotic death in breast cancer cells. Toxicology and Applied Pharmacology. 2023;462:116409. doi:10.1016/j.taap.2023.116409
BibTeX
@article{Kandhari2023,
author = {Kandhari, Kushal and Mishra, Jai P N and Agarwal, Rajesh and Singh, Rana P},
title = {Acacetin induces sustained ERK1/2 activation and RIP1-dependent necroptotic death in breast cancer cells},
journal = {Toxicology and Applied Pharmacology},
year = {2023},
volume = {462},
pages = {116409},
doi = {10.1016/j.taap.2023.116409}
}
EUVIMED